Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05978531 · ClinicalTrials.gov registry record
Observational Study of Persistence on Bafiertam Treatment in Routine Clinical Practice
A clinical trial, sponsored by Banner Life Sciences.
- Terminated
- Registry status
- 25
- Enrollment target
NCT05978531 is a clinical trial that was terminated before completion, run by Banner Life Sciences. The registered enrollment target is 25 participants.
The verdict
NCT05978531 was terminated before completion, sponsored by Banner Life Sciences.
- TERMINATED
- Registry status
- 25 participants
- Enrollment target
Study Summary
This is an open-label, multicenter, observational study of the adherence of patients with relapsing-remitting multiple sclerosis (RRMS) prescribed Bafiertam (monomethyl fumarate) as their treatment.
Interventions
- DRUG Monomethyl Fumarate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2023-08-17 |
| Est. Completion | 2025-02-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05978531
The ClinicalTrials.gov registry entry for NCT05978531 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Banner Life Sciences, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Monomethyl Fumarate is the first listed.
NCT05978531 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05978531 about?
NCT05978531 is a clinical study titled "Observational Study of Persistence on Bafiertam Treatment in Routine Clinical Practice". This is an open-label, multicenter, observational study of the adherence of patients with relapsing-remitting multiple sclerosis (RRMS) prescribed Bafiertam (monomethyl fumarate) as their treatment.
What is the current status of trial NCT05978531?
This trial is currently terminated. The enrollment target is 25 participants. The study started on 2023-08-17. Estimated completion is 2025-02-24.
What interventions are being tested in trial NCT05978531?
The interventions under investigation include: Monomethyl Fumarate (DRUG).
Who is sponsoring clinical trial NCT05978531?
This trial is sponsored by Banner Life Sciences, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.